As the battle against cancer intensifies worldwide, the global PARP inhibitor market is poised for significant expansion, projected to achieve a market worth of USD 6,279.90 million by 2024. According to recent market analysis, PARP inhibitors are anticipated to grow at a robust Compound Annual Growth Rate (CAGR) of 8.70% through 2034, with expectations to …